← Back to Clinical Trials
Recruiting NCT07380737

Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Trial Parameters

Condition Parkinson's Disease
Sponsor Tel-Aviv Sourasky Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 40 Years
Max Age 85 Years
Start Date 2025-12-29
Completion 2026-08-31
Interventions
Walking Tall App

Brief Summary

This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria); * Hoehn \& Yahr stage II-III (ON-medication state); * Able to walk independently for ≥5 minutes; * Stable medication for ≥1 month; * Currently enrolled in a rehab program at Ezra LeMarpe; * Able to provide written informed consent; Exclusion Criteria: * Musculoskeletal, neurological, or visual/hearing impairments affecting gait; * Cognitive impairments or severe behavioral symptoms; * History of stroke, severe TBI, or brain tumor; * Cardiovascular contraindications; * Inability to use a smartphone; * Participation in other concurrent intervention studies.

Related Trials